Mineralocorticoid Receptor Antagonists Unlikely to Induce Hypotension in HFrEF Mineralocorticoid Receptor Antagonists Unlikely to Induce Hypotension in HFrEF

Patients with heart failure with reduced ejection fraction (HFrEF) can be treated with mineralocorticoid receptor antagonists (MRAs) and are unlikely to develop hypotension as a result, an analysis of two large randomized trials reveals.Reuters Health Information
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Medscape Today News Source Type: news